Recent Finacing
Recent Raise
Sedia Biosciences develops and commercializes innovative in-vitro diagnostic and epidemiological tests, most notably its HIV-1 LAg-Avidity assay for measuring infection recency.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Sedia Biosciences.
